SERA PROGNOSTICS, INC. Comprehensive Income
SERA PROGNOSTICS, INC. (SERA) reported Comprehensive Income of -$9.20 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-12
- SERA PROGNOSTICS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$9.20M.
- SERA PROGNOSTICS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$8.64M.
- SERA PROGNOSTICS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$7.89M.
- SERA PROGNOSTICS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$7.69M.
- SERA PROGNOSTICS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$31.73M.
- SERA PROGNOSTICS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$32.82M.
- SERA PROGNOSTICS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$35.28M.
- SERA PROGNOSTICS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$44.98M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$9.20M 10-Q · filed 2026-08-12 | -$17.85M 10-Q · filed 2026-08-12 | -$25.73M derived: sum of 3 quarters · filed 2026-08-12 | -$33.43M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$8.64M 10-Q · filed 2026-05-06 | -$16.53M derived: sum of 2 quarters · filed 2026-05-06 | -$24.22M derived: sum of 3 quarters · filed 2026-05-06 | -$32.20M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | -$7.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$15.58M derived: sum of 2 quarters · filed 2026-03-18 | -$23.55M derived: sum of 3 quarters · filed 2026-08-12 | -$31.73M 10-K · filed 2026-03-18 |
| 2025-09-30 | -$7.69M 10-Q · filed 2025-11-13 | -$15.67M derived: sum of 2 quarters · filed 2026-08-12 | -$23.84M 10-Q · filed 2025-11-13 | -$32.65M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$7.98M 10-Q · filed 2026-08-12 | -$16.15M 10-Q · filed 2026-08-12 | -$24.96M derived: sum of 3 quarters · filed 2026-08-12 | -$32.38M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$8.17M 10-Q · filed 2026-05-06 | -$16.98M derived: sum of 2 quarters · filed 2026-05-06 | -$24.40M derived: sum of 3 quarters · filed 2026-05-06 | -$32.73M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$8.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$16.23M derived: sum of 2 quarters · filed 2026-03-18 | -$24.56M derived: sum of 3 quarters · filed 2026-03-18 | -$32.82M 10-K · filed 2026-03-18 |
| 2024-09-30 | -$7.42M 10-Q · filed 2025-11-13 | -$15.75M derived: sum of 2 quarters · filed 2025-11-13 | -$24.01M 10-Q · filed 2025-11-13 | -$31.34M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$8.33M 10-Q · filed 2025-08-06 | -$16.60M 10-Q · filed 2025-08-06 | -$23.92M derived: sum of 3 quarters · filed 2025-08-06 | -$31.07M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$8.26M 10-Q · filed 2025-05-07 | -$15.59M derived: sum of 2 quarters · filed 2025-05-07 | -$22.74M derived: sum of 3 quarters · filed 2025-05-07 | -$33.50M derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | -$7.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | -$14.48M derived: sum of 2 quarters · filed 2025-03-19 | -$25.23M derived: sum of 3 quarters · filed 2025-03-19 | -$35.28M 10-K · filed 2025-03-19 |
| 2023-09-30 | -$7.15M 10-Q · filed 2024-11-06 | -$17.91M derived: sum of 2 quarters · filed 2024-11-06 | -$27.95M 10-Q · filed 2024-11-06 | -$37.51M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$10.76M 10-Q · filed 2024-08-07 | -$20.80M 10-Q · filed 2024-08-07 | -$30.36M derived: sum of 3 quarters · filed 2024-08-07 | -$41.42M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | -$10.04M 10-Q · filed 2024-05-08 | -$19.60M derived: sum of 2 quarters · filed 2024-05-08 | -$30.66M derived: sum of 3 quarters · filed 2024-05-08 | -$42.34M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$9.56M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | -$20.62M derived: sum of 2 quarters · filed 2024-03-20 | -$32.30M derived: sum of 3 quarters · filed 2024-03-20 | -$44.98M 10-K · filed 2024-03-20 |
| 2022-09-30 | -$11.06M 10-Q · filed 2023-11-08 | -$22.75M derived: sum of 2 quarters · filed 2023-11-08 | -$35.43M 10-Q · filed 2023-11-08 | -$48.07M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$11.68M 10-Q · filed 2023-08-09 | -$24.36M 10-Q · filed 2023-08-09 | -$37.01M derived: sum of 3 quarters · filed 2023-08-09 | -$46.89M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$12.68M 10-Q · filed 2023-05-10 | -$25.32M derived: sum of 2 quarters · filed 2023-05-10 | -$35.21M derived: sum of 3 quarters · filed 2023-05-10 | -$41.51M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$12.64M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$22.53M derived: sum of 2 quarters · filed 2023-03-22 | -$28.83M derived: sum of 3 quarters · filed 2023-03-22 | -$35.19M 10-K · filed 2023-03-22 |
| 2021-09-30 | -$9.88M 10-Q · filed 2022-11-09 | -$16.19M derived: sum of 2 quarters · filed 2022-11-09 | -$22.55M 10-Q · filed 2022-11-09 | -$27.93M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$6.31M 10-Q · filed 2022-08-10 | -$12.67M 10-Q · filed 2022-08-10 | -$18.04M derived: sum of 3 quarters · filed 2022-08-10 | -$23.11M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | -$6.36M 10-Q · filed 2022-05-10 | -$11.73M derived: sum of 2 quarters · filed 2022-05-10 | -$16.81M derived: sum of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | -$5.38M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$10.45M derived: sum of 2 quarters · filed 2022-03-29 | -$19.85M 10-K · filed 2022-03-29 | |
| 2020-09-30 | -$5.07M 10-Q · filed 2021-11-09 | -$14.47M 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |